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(100 mg/m2/day for 5 days) and two
cycles of the combination Ifosfamide
(2 gr/m2/day for 5 days), Doxorubicin
(40 mg/m2/day for 2 days), Vincristine
(1.5 mg/m2). Resection of a complete
necrotic lesion at the fourth hepatic
segment was subsequently performed.
Treatment was completed with high dose
association of Melphalan (200 mg/M2) and
Vincristine (4 mg/M2) followed by auto-
logous bone marrow transplantation
(BMT). After 13 years since WT diagnosis
and 11 years after BMT the patient pre-
sented a right non tender, homogeneous
and mobile parotideal mass. After the total
parotidectomy the diagnosis was con-
sistent with a low-grade mucoepidermoidal
carcinoma. In the National WT Study
Group review regarding 43 SMNs out
of 5278 patients enrolled between 1969
and 1991 the relevant risk factor for de-
veloping a SMN were radiation therapy
(RT), the association of Doxo-rubicin and
RT and utilization of chemo-therapy
for the treatment of the relapse. All these
risk factors were present in the only repor-
ted case of parotideal carcinoma in these
series. In the SlOP survey RT was related
to secondary bone cancer and the use
of epipodophyllotoxin with leukemia occu-
rrence. On these basis in our patient
a clear pathogenetic mechanism is lac-
king, then we can also attribute the secon-
dary parotid carcinoma simply to the chan-
ce. Physician needto be aware that even
unusual SMNs, can develop also in sub-
jects that for their primary malignancy
and related treatment are at low risk.
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Purpose: The aim of this work was
to estimate the error in dose calculations,
to check the agreement between the mea-
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sured and calculated doses and to analyse
dose discrepancies in the group of thirty
patients undergoing total body irradiation.
Method: A group of thirty consecutive
patients, children aged from 5 to 12 years,
was taken for dose comparison. A combi-
nation of lateral and anterior - posterior
fields with electron boost was used in eight
fractions and on four consecutive days.
Cobalt unit was used as a source of ra-
diation. Lung shields were used· at two
anterior-posterior fields. Compensators
were attached at the neck, head and legs.
Doses were preliminarily calculated and
then measured in-vivo by thermo-
luminescent (TLD) and semiconductor
(SEM) detectors attached to the body in ten
representative transverse cross-sections.
Calculations and measurements were
carried out for the beam at the body entry
and exit. The error in dose calculations was
estimated for each dosimetrical point.
A total dose of 12,6 Gy was prescribed
in the body midline on the central beam axis
(CAX). A dose of 8.2 Gy was delivered from
six lateral fields and a dose of 4,4 Gy from
two AP/PA fields. In the lungs dose was
below 10 Gy. Lateral fields were set at
a source to skin distance (SSD) of 305 cm
with the dose rate to midline of 5,9 cGy/min
and AP/PA fields were set at 210 cm with
11,5 cGy/min, respectively. A fractional
dose specified on CAX and midline was
2.5 Gy during all anterior-posterior fields
(from each side), 1.5 Gy (0.75 Gy from each
side) during four lateral fields, and 1.1 Gy
(0.55 Gy from each side) during two lateral
fields.
Results: The error in the preliminary dose
calculations was determined by a total
differential method, taking into account
of the accuracy of determining the following
parameters: SSD, body thickness and con-
tour, the thickness of compensators, lung
shields, filter shape, lung dimensions and
body density, where applicable. Calcu-
lations were done separately for each
cross-section and for the beam entry
and exit. The values of this error were
rounded up to 3% for CAX, from 5% to 10%
for head, neck, shoulders, abdomen,
elbows, wrist, knee and feet and increased
to 15% for lung at AP/PA fields. Per cent
deviations for hole group of patients
for lateral and AP/PA fields (on entry
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and exit) were below 10 % (TLD and SEM
detectors) with the exceptions for the neck
at lateral and for the lungs at AP/PA fields
where the errors exceeded 10 %.
Conclusions: For the group of patients
the per cent deviations exceeded 10%
for the neck exit in lateral fields and for
the lung exit in anterior - posterior fields.
Standard deviations exceeded 10%
at the neck and lung exits in lateral fields
and at the lung exit in anterior - posterior
fields.
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Cord blood is a rich source of primitive
hemopoietic stem cells. In clinical hema-
tology it is transplanted instead of bone
marrow or peripheral blood stem cells.
The Institute of Hematology and Blood
Transfusion in Warsaw has had a Cord
Blood Bank (WACB) since 1997. WACB
collaborates with Eurocord Transplant
Group and with Bone Marrow Donors
Worldwide transfering data on frozen CB
intended for transplantation. During 1997 -
2000, a total of 159 unrelated and 29 re-
lated cord blood units were collected.
More than 70% of transplants of CB were
perfomed in pediatric recipiens it is nece-
ssary to reduce its volume of storage
of CB units. Separation techniques reduce
sample volume to ± 20 ml. Sedimentation
methods reduce the number of RBC to be
infused. RBC depletion reduces the risk
of incompatibile reaction. Sedimentation
reduces side-effects of the DMSO (dimethyl
sulfoxide) cytotoxity (DMSO volume is re-
duced to 4 ml).
The aim of our study was to evaluate
methods of isolating leukocytes from cord
blood within a closed system. Two me-
thods of isolation have been tested: 6%
hydroxyethyl starch in 0,9% NaCI and 3%
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gelatin in 0,9% NaCI (Gelafundine, Braun).
Centrifugation and sedimentation methods
have been used. The final volume of cord
blood was 20 ml for each unit. The best
results were obtained for sedimentation.
With 3% gelatin sedimentation 75,1%
WBC and 81,3% CD34+ were recovered,
while the waste of RBC was 97,2%;
with 6% HES sedimentation the results
were: 65%; 90,3%, and 80,5% respe-
ctively. The results of our centrifugation
methods revealed a great loss of proge-
nitor cells (approx. 40%). 6% HES and 3%
gelatin are approved for clinical use,
therefore sedimentation methods based
on these media are safe for recipients.
Furthermore, the use of closed system
recommended by Eurocord Transplant,
prevents bacterial contamination.
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Purpose: We present the role of detailed
and frequent monitoring of hematopoietic
chimerism in prediction of post-transplant
clinical outcome and our initial experience
with adoptive immunotherapy (AI) in pre-
vention and treatment of relapse in children
after allogeneic hematopoietic stem cell
transplantation (HSCT) for leukemia.
Materials and methods: Between
1/1997 and 12/2000 we performed a total
of 46 unmanipulated allogeneic HSCT
from HLA-identical siblings (MSD;23)
or matched unrelated donors (MUD;23)
in 43 consecutive children with hema-
tological malignancies (ALL 16, AML 15,
CML 5, MDS 6, JMML 3, CMML 1) with
a median age of 10,5 years. We have
analyzed hematopoietic chimerism in peri-
pheral blood samples using polymerase
chain reaction (peR) of variable number
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